Results from the Diabetes Technology Society’s Blood Glucose Meter Surveillance Program identifies only six out of 18 meters that passed. Did yours make the cut?

During the European Association for the Study of Diabetes 2022 annual meeting, diaTribe hosted its ninth annual “Solvable Problems in Diabetes” panel discussion, where...

A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...

The term “type 2 diabetes remission” continues to spark debate in the diabetes community. At the EASD 2022 annual conference in Stockholm, experts explored this concept...

Researchers presented on the exciting weight loss efficacy of tirzepatide. While tirzepatide has not yet been approved for weight loss, the SURMOUNT clinical trial...

diaTribe is excited to bring you additional expanded coverage from the EASD 2022 conference! Hear from leading clinicians and researchers around the world on insights...

The Diabetes Education Study Group (DESG) hosted a panel at this year’s EASD in which panelists provided an overview of recent evidence supporting education about...

The number of youths being diagnosed with type 2 diabetes each year is on the rise. Learn about the early signs of type 2 diabetes in children and adolescents, the...

How to be a better patient and health care provider - Dr. Anne Peter’s top ten actionable tips for people with diabetes.

How to deal when your life (and your diabetes) gets complicated.

Interview with Phil Southerland: what is most misunderstood and why winning races is not the whole story. Prepare to be inspired!

What readers have taught me in the past year about living better with diabetes

Kelly Close and Adam Brown led two panels on next-generation diabetes at The diaTribe Foundation’s third annual gathering during ADA 2018; plus highlights from the “...

At our virtual Musings Under the Moon #8 gathering, experts in health equity gathered to discuss what health equity really means, what its barriers are, and what actions...

The Libre Sense CGM is similar to the Freestyle Libre 2, but it’s made for athletes and not for people with diabetes

Public speaking professor Alan Uphold shares his experiences with severe low blood sugars and explains why it’s so important to communicate with your loved ones and care...

Two important studies on thiazolidinediones (TZDs), a class of insulin sensitizers, were published in November and December of 2006.

An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...

The latest advances in diabetes care have led to several new tools to help people with type 2 diabetes lower their glucose, lose weight, and prevent complications. From...

What is cholesterol, and when is it “good” or “bad?” What are the cholesterol recommendations for people with diabetes, and how can you keep up healthy cholesterol...